These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6940407)

  • 1. Progression of glomerular structural kidney alterations in diabetic rat and man.
    Osterby R; Gøotzsche O; Gundersen HJ; Hirose K; Iundbaek K; Seyer-Hansen K
    Acta Endocrinol Suppl (Copenh); 1981; 242():63-4. PubMed ID: 6940407
    [No Abstract]   [Full Text] [Related]  

  • 2. [Glomerulosclerosis in diabetic animals].
    Ditscherlein G
    Z Gesamte Inn Med; 1970 Apr; 25(7):281-9. PubMed ID: 4939825
    [No Abstract]   [Full Text] [Related]  

  • 3. Islet transplantation in experimental diabetes of the rat. V. Regression of glomerular lesions in diabetic rats after intraportal transplantation of isogeneic islets. Preliminary results.
    Federlin K; Bretzel RG; Schmidtchen U
    Horm Metab Res; 1976 Sep; 8(5):404-6. PubMed ID: 135720
    [No Abstract]   [Full Text] [Related]  

  • 4. Disparate effects of castration on renal structure and function in the streptozotocin diabetic rat.
    Bach LA; Cooper ME; Vranes D; Allen TJ; Rumble J; Jerums G
    Diabetes Res; 1994; 27(1):27-38. PubMed ID: 7648794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glomerular structural changes in pregnant, diabetic, and pregnant-diabetic rats.
    Rasch R; Lauszus F; Thomsen JS; Flyvbjerg A
    APMIS; 2005; 113(7-8):465-72. PubMed ID: 16086816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of glomerular filtration and plasma flow in experimental diabetic rats.
    Michels LD; Davidman M; Keane WF
    J Lab Clin Med; 1981 Dec; 98(6):869-85. PubMed ID: 7031154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereological estimates of volume-weighted mean glomerular volume in streptozotocin-diabetic rats.
    Artacho-Perula E; Roldan-Villalobos R; Salcedo-Leal I; Vaamonde-Lemos R
    Lab Invest; 1993 Jan; 68(1):56-61. PubMed ID: 8423677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can adequate control of diabetes prevent the development of vascular complications? A mini review.
    Ostman J
    Acta Med Scand Suppl; 1983; 671():5-10. PubMed ID: 6349266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney lesions in rats with severe long term alloxan diabetes. 3. Glomerular ultrastructure.
    Hansen RO; Lundbaek K; Olsen TS; Orskov H
    Lab Invest; 1967 Dec; 17(6):675-92. PubMed ID: 6074498
    [No Abstract]   [Full Text] [Related]  

  • 10. Moon-crater formation on the glomerular basement membrane in human and experimental diabetes.
    Hansen RO; Olsen TS
    Acta Pathol Microbiol Scand; 1967; 71(2):318-20. PubMed ID: 5582851
    [No Abstract]   [Full Text] [Related]  

  • 11. Morphometric detection of incipient glomerular lesions in diabetic nephropathy in rats. Protective effects of ACE inhibition.
    Sassy-Prigent C; Heudes D; Jouquey S; Auberval D; Belair MF; Michel O; Hamon G; Bariety J; Bruneval P
    Lab Invest; 1995 Jul; 73(1):64-71. PubMed ID: 7603042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats.
    Samnegård B; Jacobson SH; Jaremko G; Johansson BL; Ekberg K; Isaksson B; Eriksson L; Wahren J; Sjöquist M
    Nephrol Dial Transplant; 2005 Mar; 20(3):532-8. PubMed ID: 15665028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
    Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant glomerular basement membrane thickening in hyperglycemic and normoglycemic diabetic-prone BB Wistar rats.
    Carlson EC; Vari RC; Audette JL; Finke MA; Ressler MJ
    Anat Rec A Discov Mol Cell Evol Biol; 2004 Dec; 281(2):1308-18. PubMed ID: 15532046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetic micro-angiopathy (3): micro-angiopathy in diabetic animals].
    Hägg E
    Lakartidningen; 1969 Oct; 66(42):4323-8. PubMed ID: 4985928
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased glomerular alpha 1 (IV) collagen expression and deposition in long-term diabetic rats is prevented by chronic glycosaminoglycan treatment.
    Ceol M; Nerlich A; Baggio B; Anglani F; Sauer U; Schleicher E; Gambaro G
    Lab Invest; 1996 Feb; 74(2):484-95. PubMed ID: 8780166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anionic charge sites in the kidney: comparison of two diabetic rat models.
    Ward-Cook KM; Mahan JD; Frenchko CE; Albright A; Chiasera JM; McAllister C
    Ann Clin Lab Sci; 1999; 29(4):286-98. PubMed ID: 10528828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An impairment of barrier size and charge selectivity of glomerular basement membrane in streptozotocin-induced diabetes and prevention by pharmacological therapy.
    Isogai S; Mogami K; Ouchi H; Yoshino G
    Med Electron Microsc; 2000; 33(3):123-9. PubMed ID: 11810469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin prevents early steps of the development of diabetic nephropathy in rats.
    Yang Y; Wang J; Qin L; Shou Z; Zhao J; Wang H; Chen Y; Chen J
    Am J Nephrol; 2007; 27(5):495-502. PubMed ID: 17671379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibitory effect of elastase on diabetic nephropathy in experimental diabetic mice].
    Fujii W
    Hokkaido Igaku Zasshi; 2002 Sep; 77(5):429-38. PubMed ID: 12404758
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.